White label ELPA - ClinicalTrials.eu

Study on the Safety and Effectiveness of Human Alpha1-Proteinase Inhibitor for Preventing Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplant.

Not recruiting

4 1 1
Investigated diseases:
- Graft versus host disease
Study on PET Tracers [18F]F-AraG and [89Zr]Zr-Df-Crefmirlimab for Evaluating T Cell Activation in Non-Small Cell Lung Cancer Patients

Not recruiting

4 1 1 1
Investigated diseases:
Study on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy

Not recruiting

2 1 1
Investigated diseases:
- Ischaemic stroke
Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Not recruiting

2 1

+14
Study on the Effectiveness and Safety of RO7198457 and Pembrolizumab for Patients with Untreated Advanced Melanoma

Not recruiting

2 1 1 1
Investigated diseases:
Study of Trastuzumab Deruxtecan for Patients with HER2-Low Breast Cancer and New or Worsening Brain Metastases

Not recruiting

2 1 1
Investigated diseases:
- HER2 negative breast cancer
- Metastases to central nervous system
Study of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation

Not recruiting

1 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Study comparing darolutamide versus hormone therapy (goserelin, leuprorelin, triptorelin, degarelix) in men with untreated hormone-sensitive prostate cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Hormone-dependent prostate cancer
Study of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia

Not recruiting

3 1 1 1

+3
Study on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients

Not recruiting

2 1
Investigated diseases:
- Cognitive disorder
- Schizophrenia

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies